CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes [Phase 2]

Phase 2 trial comparing once-daily vs three-times-daily dosing of ORMD-0801 in adults with Type 1 Diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Oramed, Ltd. | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2022-06-02